Coccidioidomycosis

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Coccidiomycosis)
Jump to: navigation, search
Coccidioidomycosis
Classification and external resources
Histopathological changes in a case of coccidioidomycosis of the lung showing a large fibrocaseous nodule.
ICD-10 B38.
ICD-9 114
MedlinePlus 001322
eMedicine med/103  ped/423
MeSH D003047

WikiDoc Resources for

Coccidioidomycosis

Articles

Most recent articles on Coccidioidomycosis

Most cited articles on Coccidioidomycosis

Review articles on Coccidioidomycosis

Articles on Coccidioidomycosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Coccidioidomycosis

Images of Coccidioidomycosis

Photos of Coccidioidomycosis

Podcasts & MP3s on Coccidioidomycosis

Videos on Coccidioidomycosis

Evidence Based Medicine

Cochrane Collaboration on Coccidioidomycosis

Bandolier on Coccidioidomycosis

TRIP on Coccidioidomycosis

Clinical Trials

Ongoing Trials on Coccidioidomycosis at Clinical Trials.gov

Trial results on Coccidioidomycosis

Clinical Trials on Coccidioidomycosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Coccidioidomycosis

NICE Guidance on Coccidioidomycosis

NHS PRODIGY Guidance

FDA on Coccidioidomycosis

CDC on Coccidioidomycosis

Books

Books on Coccidioidomycosis

News

Coccidioidomycosis in the news

Be alerted to news on Coccidioidomycosis

News trends on Coccidioidomycosis

Commentary

Blogs on Coccidioidomycosis

Definitions

Definitions of Coccidioidomycosis

Patient Resources / Community

Patient resources on Coccidioidomycosis

Discussion groups on Coccidioidomycosis

Patient Handouts on Coccidioidomycosis

Directions to Hospitals Treating Coccidioidomycosis

Risk calculators and risk factors for Coccidioidomycosis

Healthcare Provider Resources

Symptoms of Coccidioidomycosis

Causes & Risk Factors for Coccidioidomycosis

Diagnostic studies for Coccidioidomycosis

Treatment of Coccidioidomycosis

Continuing Medical Education (CME)

CME Programs on Coccidioidomycosis

International

Coccidioidomycosis en Espanol

Coccidioidomycosis en Francais

Businness

Coccidioidomycosis in the Marketplace

Patents on Coccidioidomycosis

Experimental / Informatics

List of terms related to Coccidioidomycosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Coccidioidomycosis (also known as Valley fever, San Joaquin Valley Fever, California valley fever, desert fever, and (incorrectly) coccidiomycosis) is a fungal disease caused by Coccidioides immitis or C. posadasii.[1] It is endemic in certain parts of Arizona, California, Nevada, New Mexico, Texas, Utah and northwestern Mexico.[1]

C. immitis resides in the soil in certain parts of the southwestern United States, northern Mexico, and parts of Central and South America [3]. It is dormant during long dry spells, then develops as a mold with long filaments that break off into airborne spores when the rains come. The spores, known as arthroconidia, are swept into the air by disruption of the soil, such as during construction or farming. Infection is caused by inhalation of the particles. The disease is not transmitted from person to person. C. immitis is a dimorphic saprophytic organism that grows as a mycelium in the soil and produces a spherule form in the host organism.

The disease is usually mild, with flu-like symptoms and rashes, and the Mayo Clinic estimates that half the population in some affected areas have suffered from the disease. On occasion, those particularly susceptible, including pregnant women, people with weakened immune systems, and those of Asian, Hispanic and African descent, may develop a serious or even fatal illness from valley fever. Serious complications include severe pneumonia, lung nodules, and disseminated disease, where the fungus spreads throughout the body. The disseminated form of valley fever can devastate the body, causing skin ulcers and abscesses to bone lesions, severe joint pain, heart inflammation, urinary tract problems, meningitis, and death.

It has been known to infect humans, dogs, cattle, livestock, llamas, apes, monkeys, kangaroos, wallabies, tigers, bears, badgers, otters and marine mammals. [1]

Symptomatic infection (40% of cases) usually presents as an influenza-like illness with fever, cough, headaches, rash, and myalgia (muscle pain).[1] Some patients fail to recover and develop chronic pulmonary infection or widespread disseminated infection (affecting meninges, soft tissues, joints, and bone). Severe pulmonary disease may develop in HIV-infected persons.[1] The disease can be fatal.

Geographic distribution of coccidioidomycosis.
Geographic distribution of coccidioidomycosis.

Occurrence

California state prisons have been particularly affected by Coccidioidomycosis, as far back as 1919. In 2005 and 2006, the Pleasant Valley State Prison near Coalinga and Avenal State Prison near Avenal on the western side of the San Joaquin Valley had the highest incidence rate in 2005, of at least 3,000 per 100,000 [4].

Biological Warfare

C. immitis was investigated by the United States during the 1950s and 1960s as a potential biological weapon. The Cash strain received the military symbol OC, and original hopes were for its use as an incapacitant. As medical epidemiology later made clear, OC would have lethal effects on several segments of the population, so it was later considered a lethal agent. It was never standardized, and beyond a few field trials, it was never weaponized. Most military work on OC was on vaccines by the mid-1960s.

Diagnostic test

The fungal infection can be demonstrated by microscopic detection of diagnostic cells in body fluids, exudates, sputum and biopsy-tissue. With specific nucleotide primers C.immitis DNA can be amplified by PCR. It can also be detected in culture by morphological identification or by using molecular probes that hybridize with C.immitis RNA. An indirect demonstration of fungal infection can be achieved also by serologic analysis detecting fungal antigen or host antibody produced against the fungus.

Popular culture

The illness is mentioned in episode Lines in the Sand of the TV Show House, as the cause of a young girl's loss of inhibition. The illness does not actually cause loss of inhibition, nor does it cause milky tears. This was not a factual error in the episode: House was tricking the girl, however this was not obvious to many viewers.

It is also the center of an episode of the TV series Bones, The Man In the Fallout Shelter. After being exposed to the fungus, the team was quarantined over Christmas to determine whether or not they had become infected. It was erroneously claimed to be contagious from person to person.

References

External links

de:Kokzidioidomykosenl:Coccidioidomycose
WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
In other languages